MICAFUNGIN IN SODIUM CHLORIDE 0.9% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Micafungin In Sodium Chloride 0.9%, and when can generic versions of Micafungin In Sodium Chloride 0.9% launch?
Micafungin In Sodium Chloride 0.9% is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in MICAFUNGIN IN SODIUM CHLORIDE 0.9% is micafungin sodium. There are eight drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the micafungin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Micafungin In Sodium Chloride 0.9%
A generic version of MICAFUNGIN IN SODIUM CHLORIDE 0.9% was approved as micafungin sodium by FRESENIUS KABI USA on May 17th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MICAFUNGIN IN SODIUM CHLORIDE 0.9%?
- What are the global sales for MICAFUNGIN IN SODIUM CHLORIDE 0.9%?
- What is Average Wholesale Price for MICAFUNGIN IN SODIUM CHLORIDE 0.9%?
Summary for MICAFUNGIN IN SODIUM CHLORIDE 0.9%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 58 |
| DailyMed Link: | MICAFUNGIN IN SODIUM CHLORIDE 0.9% at DailyMed |
Recent Clinical Trials for MICAFUNGIN IN SODIUM CHLORIDE 0.9%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wake Forest University Health Sciences | Phase 4 |
| Scynexis, Inc. | Phase 3 |
| Yung Shin Pharm. Ind. Co., Ltd. | Phase 4 |
Pharmacology for MICAFUNGIN IN SODIUM CHLORIDE 0.9%
| Drug Class | Echinocandin Antifungal |
US Patents and Regulatory Information for MICAFUNGIN IN SODIUM CHLORIDE 0.9%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | micafungin sodium | SOLUTION;INTRAVENOUS | 216142-001 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare Corp | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | micafungin sodium | SOLUTION;INTRAVENOUS | 216142-002 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare Corp | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | micafungin sodium | SOLUTION;INTRAVENOUS | 216142-003 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
